This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barron, H. V. Search for Related Content PubMed PubMed Citation Articles by Barron, H. V.

Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2

Hal V. Barron, MD, FACC^* , Andrew D. Michaels, MD^*, Charles Maynard, PhD, Nathan R. Every, MD, MPH for the National Registry of Myocardial Infarction 2 Participants

^* Department of Medicine, Division of Cardiology, University of California–San Francisco Medical Center, San Francisco, California, USA
Genentech, Inc., South San Francisco, California, USA
Myocardial Infarction Triage and Intervention (MITI) Coordinating Center, Seattle, Washington, USA

View larger version (24K): [in a new window]   Figure 1 Discharge ACE inhibitor use by clinical indication group.

View larger version (11K): [in a new window]   Figure 2 Discharge ACE inhibitor (squares) and calcium channel blocker (circles) use by time period.